BridgeBio Pharma: 4Q Earnings Snapshot

February 25, 2021 GMT

PALO ALTO, Calif. (AP) _ BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $120 million in its fourth quarter.

The Palo Alto, California-based company said it had a loss of $1.01 per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.

The rare disease drug developer posted revenue of $122,000 in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $15.3 million.

For the year, the company reported that its loss widened to $448.7 million, or $3.80 per share. Revenue was reported as $8,000.


BridgeBio Pharma shares have fallen 5% since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBIO at https://www.zacks.com/ap/BBIO